טוען...
AAV-mediated local delivery of interferon-β for the treatment of retinoblastoma in preclinical models
Interferon-β (IFN-β has been found to have anti-tumor properties against a variety of malignancies through different mechanisms. However, clinical trials involving systemic administration of IFN-β have been hampered by secondary toxicity and the short half-life of IFN-β in the circulation. In order...
שמור ב:
Main Authors: | , , , , , , |
---|---|
פורמט: | Artigo |
שפה: | Inglês |
יצא לאור: |
2009
|
נושאים: | |
גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2725441/ https://ncbi.nlm.nih.gov/pubmed/19306089 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12017-009-8059-0 |
תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|